Neuralgia News and Research

RSS
Neuralgia is pain in one or more nerves that occurs without stimulation of pain receptor (nociceptor) cells. Neuralgia pain is produced by a change in neurological structure or function rather than by the excitation of pain receptors that causes nociceptive pain.
XenoPort first quarter revenues increase to $10.4 million

XenoPort first quarter revenues increase to $10.4 million

Impax initiates challenge of patents related to generic Gralise

Impax initiates challenge of patents related to generic Gralise

NIH awards Winston SBIR grant to develop Civamide for postherpetic neuralgia of TN

NIH awards Winston SBIR grant to develop Civamide for postherpetic neuralgia of TN

Merck announces data from ZOSTAVAX Phase III study on shingles

Merck announces data from ZOSTAVAX Phase III study on shingles

Nerve pain patients in Wales gain access to first of a kind treatment which can provide lasting pain relief

Nerve pain patients in Wales gain access to first of a kind treatment which can provide lasting pain relief

Convergence initiates CNV1014802 Phase II study in trigeminal neuralgia

Convergence initiates CNV1014802 Phase II study in trigeminal neuralgia

American Shared Hospital Services fourth quarter revenues increase 8.4% to $4,500,000

American Shared Hospital Services fourth quarter revenues increase 8.4% to $4,500,000

EpiCept fourth quarter revenue decreases to $0.2 million

EpiCept fourth quarter revenue decreases to $0.2 million

Depomed, Santarus reach agreement to resolve GLUMETZA patent litigation with Lupin

Depomed, Santarus reach agreement to resolve GLUMETZA patent litigation with Lupin

EpiCept seeks FDA Fast Track designation for AmiKet to treat CIPN

EpiCept seeks FDA Fast Track designation for AmiKet to treat CIPN

Takeda receives FDA approval for VELCADE sNDA to treat MM

Takeda receives FDA approval for VELCADE sNDA to treat MM

Arcion receives U.S. patent allowance for ARC-2022 to treat PHN

Arcion receives U.S. patent allowance for ARC-2022 to treat PHN

Positive results from Aestus' ATx08-001 Phase II study on post-herpetic neuralgia

Positive results from Aestus' ATx08-001 Phase II study on post-herpetic neuralgia

Medical websites provide harmful information about postherpetic neuralgia treatments

Medical websites provide harmful information about postherpetic neuralgia treatments

Neuropharmacology to publish Nutra Pharma's Alpha-Cobratoxin mechanism study on chronic pain

Neuropharmacology to publish Nutra Pharma's Alpha-Cobratoxin mechanism study on chronic pain

American Shared Hospital Services third quarter revenue increases to $9,148,000

American Shared Hospital Services third quarter revenue increases to $9,148,000

AMS pleased with CMS' increase in 2012 payment rate for proton therapy

AMS pleased with CMS' increase in 2012 payment rate for proton therapy

Inhibitex third quarter revenue increases to $1.3 million

Inhibitex third quarter revenue increases to $1.3 million

Takeda receives FDA approval for VELCADE sNDA to treat MM

Takeda receives FDA approval for VELCADE sNDA to treat MM

DARA BioSciences' KRN5500 reduces neuropathic pain in patients with cancer

DARA BioSciences' KRN5500 reduces neuropathic pain in patients with cancer